94748 Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices 

TABLE 1—FISCAL YEAR 2024 DISASTER-RECOVERY ADJUSTED FMAP RATES

State Fiscal year 

2023 FMAP 

Fiscal year 

2024 regular 

FMAP 

(unadjusted) 

Decrease 

in FMAP 

Disaster-recovery 

adjustment * 

Disaster-recovery 

adjusted 

FMAP fiscal 

year 2024 

Arizona ............................................................. 69.56 66.29 3.27 1.64 67.93 

* In the first year, the Disaster-Recovery Adjustment is 50 percent of the percentage point decrease between the regular FMAP for such fiscal 

year and the FMAP from the preceding fiscal year. 

TABLE 2—FISCAL YEAR 2025 DISASTER-RECOVERY ADJUSTED FMAP RATES

State Fiscal year 

2024 FMAP * 

Fiscal year 

2025 regular 

FMAP 

(unadjusted) 

Decrease 

in FMAP 

Disaster-recovery 

adjustment ** 

Disaster-recovery 

adjusted 

FMAP fiscal 

year 2025 

Arizona ............................................................. 67.93 64.89 3.04 0.76 65.65 

* Includes applicable Disaster-Recovery Adjustment made for Fiscal Year 2024 (See Table 1). 

** In year two or any succeeding fiscal year in the qualifying seven-year period, the Disaster-Recovery Adjustment is 25 percent of the percentage point decrease between the regular FMAP for such fiscal year and the FMAP from the preceding fiscal year, including any disaster-recovery 

adjustments. 

[FR Doc. 2024–27938 Filed 11–27–24; 8:45 am] 

BILLING CODE 4150–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meetings of the Presidential Advisory 

Council on Combating AntibioticResistant Bacteria 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that an in-person meeting is scheduled 

to be held for the Presidential Advisory 

Council on Combating AntibioticResistant Bacteria (PACCARB); the main 

focus of the meeting is to solicit 

feedback from invited presenters and 

members of the public on the 2025– 

2020 National Action Plan on 

Combating Antibiotic Resistant Bacteria. 

The meeting will be open to the public 

as well as streamed live on hhs.gov/live. 

A pre-registered public comment and 

innovation spotlight session will be 

held during the meeting. Pre-registration 

is required for members of the public 

who wish to present their comments or 

innovations live during the meeting. 

DATES: The meeting is scheduled to be 

held on January 28–29, 2025, from 9 

a.m. to 5 p.m. ET (times are tentative 

and subject to change). The confirmed 

times and agenda items for the meeting 

will be posted on the website for the 

PACCARB at https://www.hhs.gov/ 

paccarb when this information becomes 

available. Pre-registration for attending 

the meeting is strongly suggested and 

should be completed no later than 

January 24, 2025. 

ADDRESSES: The meeting will be held inperson at The Ritz-Carlton, Pentagon 

City, 1250 S. Hayes St., Arlington, VA 

22202. The meeting will also be live 

streamed and can be accessed through a 

live webcast on the day of the meeting. 

Additional instructions regarding 

attending this meeting virtually will be 

posted at least one week prior to the 

meeting at: https://www.hhs.gov/ 

paccarb. 

Individuals who wish to send in their 

written public comment should submit 

it via email to CARB@hhs.gov. 

Registration information is available on 

the website https://www.hhs.gov/ 

paccarb and must be completed by 

January 24, 2025, to attend the January 

28–29, 2025, public meeting or by 

January 21, 2025, to provide public 

comment or innovation spotlight at the 

meeting. Additional information about 

registering for the meeting and 

providing public comment can be 

obtained at https://www.hhs.gov/ 

paccarb on the Upcoming Meetings 

page. 

FOR FURTHER INFORMATION CONTACT: 

Jomana Musmar, M.S., Ph.D., 

Designated Federal Officer, Presidential 

Advisory Council on Combating 

Antibiotic-Resistant Bacteria, Office of 

the Assistant Secretary for Health, U.S. 

Department of Health and Human 

Services, 1101 Wootton Parkway, 

Rockville, MD 20852. Phone: 202–746– 

1512; Email: CARB@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Presidential Advisory Council on 

Combating Antibiotic-Resistant Bacteria 

(PACCARB), established by Executive 

Order 13676, is continued by section 

505 of Public Law 116–22, the 

Pandemic and All-Hazards 

Preparedness and Advancing Innovation 

Act of 2019 (PAHPAIA). Activities and 

duties of the PACCARB are governed by 

the provisions of the Federal Advisory 

Committee Act (FACA), Public Law 92– 

463, as amended (5 U.S.C. app.), which 

sets forth standards for the formation 

and use of Federal advisory committees. 

The PACCARB shall advise and 

provide information and 

recommendations to the Secretary of 

Health and Human Services (Secretary) 

regarding programs and policies 

intended to reduce or combat antibioticresistant bacteria that may present a 

public health threat and improve 

capabilities to prevent, diagnose, 

mitigate, or treat such resistance. The 

PACCARB shall function solely for 

advisory purposes. 

Such advice, information, and 

recommendations may be related to 

improving: the effectiveness of 

antibiotics; research and advanced 

research on, and the development of, 

improved and innovative methods for 

combating or reducing antibiotic 

resistance, including new treatments, 

rapid point-of-care diagnostics, 

alternatives to antibiotics, including 

alternatives to animal antibiotics, and 

antimicrobial stewardship activities; 

surveillance of antibiotic-resistant 

bacterial infections, including publicly 

available and up-to-date information on 

resistance to antibiotics; education for 

health care providers and the public 

with respect to up-to-date information 

on antibiotic resistance and ways to 

reduce or combat such resistance to 

antibiotics related to humans and 

animals; methods to prevent or reduce 


khammond on DSK9W7S144PROD with NOTICES
Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices 94749 

1 Modernization of Compliance Program 

Guidance Documents, 88 FR 25000 (Apr. 25, 2023). 

2All CPGs issued to date are currently available 

on the Compliance Guidance page of our website 

at https://oig.hhs.gov/compliance/complianceguidance/ (last visited Nov. 15, 2024). 

3To join OIG’s listserv, visit https://

cloud.connect.hhs.gov/OIG/. 

the transmission of antibiotic-resistant 

bacterial infections; including 

stewardship programs; and coordination 

with respect to international efforts in 

order to inform and advance the United 

States capabilities to combat antibiotic 

resistance. 

The focus of the January 28–29, 2025, 

meeting is to provide input and 

information to the Combating 

Antibiotic-Resistant Bacteria (CARB) 

Federal Task Force as they develop the 

next five-year iteration of the CARB 

National Action Plan 2025–2030. The 

meeting will focus on innovative and 

emerging topics in antimicrobial 

resistance (AMR), as well as insights 

from international CARB counterparts. 

The topics presented at the public 

meeting include: an overview of other 

partner country CARB National Action 

Plans; methods to measure global 

awareness of AMR; the impact of AMR 

and food security; AMR as a national 

security threat; a reflection on the 

United Nations General Assembly 

Political Declaration by Federal 

agencies; the economics of AMR; 

innovations to combat AMR; among 

other topics. 

Members of the public are invited to 

provide comment, especially on the 

2025–2030 CARB National Action Plan, 

during an extended public comment 

session, in-person during the meeting by 

pre-registering online at https://

www.hhs.gov/paccarb; pre-registration 

is required for participation in this 

session. Additionally, companies or 

organizations working to combat 

antimicrobial resistance my share their 

innovation during the January meeting 

by pre-registering to speak during the 

meeting’s Innovation Spotlight. Preregistration online at https://

www.hhs.gov/paccarb is required for 

participation in this session, and limited 

spots are available. The meeting agenda 

will be posted on the PACCARB website 

at https://www.hhs.gov/paccarb when it 

has been finalized. All agenda items are 

tentative and subject to change. 

Instructions regarding attending the 

meeting virtually will be posted at least 

one week prior to the meeting at: 

https://www.hhs.gov/paccarb. For those 

unable to attend in person, but who 

wish to provide input into the next 

iteration of the CARB National Action 

Plan 2025–2030, may provide written 

public comments that can be emailed to 

CARB@hhs.gov by midnight January 21, 

2025. All public comments received via 

email prior to January 21, 2025, will be 

provided to the PACCARB and 

Interagency CARB Task Force members. 

Dated: November 18, 2024. 

Jomana F. Musmar, 

Designated Federal Officer, Presidential 

Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant 

Secretary for Health. 

[FR Doc. 2024–28075 Filed 11–27–24; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of Inspector General 

General Compliance Program 

Guidance; Industry Segment-Specific 

Compliance Program Guidance for 

Skilled Nursing Facilities and Nursing 

Facilities; Resources for Industry; 

Availability 

AGENCY: Office of Inspector General 

(OIG), Department of Health and Human 

Services (HHS). 

ACTION: Notice of availability. 

SUMMARY: OIG is announcing the 

availability of the following resources 

for industry: General Compliance 

Program Guidance (GCPG) and Industry 

Segment-Specific Compliance Program 

Guidance for Skilled Nursing Facilities 

and Nursing Facilities (Nursing Facility 

ICPG). 

ADDRESSES: You may submit written 

electronic comments on these resources 

at any time by emailing Compliance@

oig.hhs.gov. 

FOR FURTHER INFORMATION CONTACT: 

GCPG: Contact Amanda Copsey, (202) 

577–6982, or Laura Ellis, (202) 834– 

1665. 

Nursing Facility ICPG: Contact Laura 

Morgan, (240) 930–2425, or Felicia 

Heimer, (202) 770–7017. 

SUPPLEMENTARY INFORMATION: 

I. Background 

On April 24, 2023, OIG announced 1

its plans to improve and update existing 

OIG Compliance Program Guidance 

documents (CPGs) and to deliver new 

CPGs specific to segments of the health 

care industry and entities involved in 

the health care industry that have 

emerged in recent years. 

Our April 2023 announcement 

explained, in part, that: 

• OIG developed CPGs as voluntary, 

nonbinding guidance documents to 

encourage the development and use of 

internal controls to monitor adherence 

to applicable statutes, regulations, and 

program requirements. 

• OIG will no longer publish updated 

or new CPGs in the Federal Register. 

All current, updated, and new CPGs 

will be available on our website.2

• OIG has developed a new format for 

CPGs: 

Æ First, the GCPG pertains to all 

individuals and entities involved in the 

health care industry. 

Æ Second, industry segment-specific 

CPGs (ICPGs) pertain to different types 

of providers, suppliers, and other 

participants in health care industry 

subsectors or ancillary industry sectors 

relating to Federal health care programs. 

Please reference the April 2023 

announcement for additional details. 

II. Notice of Availability 

Through this Notice of Availability, 

OIG is announcing the availability of the 

following documents: 

• GCPG: This document was 

published on OIG’s website on 

November 6, 2023. OIG notified the 

public of the publication of the GCPG 

using our public listserv 3 and other 

communications platforms. The GCPG 

may be viewed and downloaded at 

https://oig.hhs.gov/compliance/generalcompliance-program-guidance/ and 

https://oig.hhs.gov/documents/ 

compliance-guidance/1135/HHS-OIGGCPG-2023.pdf. 

• Nursing Facility ICPG: This 

document was published on OIG’s 

website on November 20, 2024. OIG is 

notifying the public of the publication 

of the Nursing Facility ICPG using our 

public listserv and other 

communications platforms. The Nursing 

Facility ICPG may be viewed and 

downloaded at https://oig.hhs.gov/ 

compliance/nursing-facility-icpg and 

https://oig.hhs.gov/documents/ 

compliance/10038/nursing-facilityicpg.pdf. 

These resources are not one-size-fitsall, comprehensive, or all-inclusive of 

compliance and quality considerations 

or risks. They are not binding on any 

individual or entity. Of note, OIG uses 

the word ‘‘should’’ in the GCPG and 

Nursing Facility ICPG to present 

voluntary, nonbinding guidance. This 

means that the documents do not create 

any new obligations or standards for any 

individual or entity. 

OIG may update the GCPG and 

Nursing Facility ICPG periodically to 

address newly identified risk areas and 

compliance and quality measures, 

ensure timely and meaningful OIG 

resources, and respond to stakeholder 

feedback. In addition, OIG anticipates 


khammond on DSK9W7S144PROD with NOTICES